The impact of primary tumor site on outcomes of treatment with etoposide and cisplatin in grade 3 gastroenteropancreatic neuroendocrine carcinoma

Background: Gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC) is a heterogeneous disease in terms of embryonic origin, aggressiveness, prognosis, and genomic profiling. Data regarding the efficacy of etoposide and cisplatin (EP) as a standard treatment of the primary tumor site in GEP-NEC ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Sang Eun, Kim, Jung Hoon, Lee, Su Jin, Lee, Jeeyun, Park, Se Hoon, Park, Joon Oh, Lim, Ho Yeong, Kang, Won Ki, Park, Young Suk, Kim, Seung Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603380/
https://www.ncbi.nlm.nih.gov/pubmed/31289584
http://dx.doi.org/10.7150/jca.30355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603380/
https://www.ncbi.nlm.nih.gov/pubmed/31289584
http://dx.doi.org/10.7150/jca.30355

Ejemplares similares